Transwell assays showed a similar result whereby sh-E2F6 could inhibit the migration and invasion of glioma cells, and the inhibitory effect could be partly reversed by miR-641 inhibitor (Figures 7I–L). Here, E2F6 is linked to central nervous system cancer.